Spineway SA
Research Spineway SA (37S) on Bullrun: market cap EUR 4.43M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker37S
- ExchangeF
- CountryFrance
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 4.43M
- Financial periodFY2025
- RevenueEUR 12.43M
- Revenue growth4.0%
- Net income-EUR 2.24M
- Free cash flow-EUR 163.00K
- Gross margin72.5%
Valuation Snapshot
latest market cap is EUR 4.43M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 12.43M | -EUR 2.24M | -EUR 163.00K | 72.5% | n/a | EUR 3.50M | EUR 1.53M | EUR 23.06M |
| FY2024 | EUR 11.95M | -EUR 3.87M | -EUR 3.27M | 70.7% | n/a | EUR 4.52M | EUR 1.82M | EUR 24.24M |
| FY2023 | EUR 10.52M | -EUR 6.51M | -EUR 7.29M | 74.9% | -0.82 | EUR 1.80M | EUR 2.60M | EUR 19.05M |
| FY2022 | EUR 7.43M | -EUR 3.14M | -EUR 1.62M | 80.5% | 0 | EUR 5.53M | EUR 2.92M | EUR 22.01M |
| FY2021 | EUR 4.29M | -EUR 1.58M | -EUR 1.80M | 80.7% | -0.2 | EUR 13.89M | EUR 2.40M | EUR 20.88M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 4.43M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Spineway SA
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Spineway SA's market cap?
Spineway SA's market capitalization is EUR 4.43M.
What does Spineway SA do?
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.